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INTRODUCTION
Tetralogy of Fallot (TOF) is a most common cyanotic 
congenital heart disease characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (1). Children with TOF are susceptible to serious 
neurological complications like cerebrovascular accidents 
(stroke) and brain abscess, which are mainly responsible 
for mortality and morbidity in these patients (1, 3). The 
incidence of cerebrovascular accidents and brain 
abscess in patients with TOF has been documented in 
Western literature as 8.6% and 13.7% respectively 2. 
Cerebrovascular accident is more common in children 
less than 2 years of age while brain abscess usually 
occur above 2 years of age. Brain abscess is a life 
threatening infection of brain parenchyma, but it is less 
common than cerebrovascular accidents because most 
patients of TOF are repaired at younger age (1). The 
extent of the neurological deficit depends largely upon 
the early detection of these complications. The early 
diagnosis of cerebrovascular accidents is important to 
prevent further recurrences (4), while the early detection 
of brain abscess is helpful for prompt management (5, 6). 
The advent of CT scan has resulted in fourfold decrease 
in mortality in these patients due to prompt identification 
and early intervention (7, 8). We observed that unlike 
developed countries, in developing countries like 
Pakistan children with TOF are more susceptible to 
adverse neurological complications especially the brain 
abscess due to delay in the surgical repair of TOF. 
To-date limited data is available regarding the frequency
of these complications in children with TOF. We 
speculated that by documenting the frequencies of 
these neurological complications, we can have high 
index of suspicion of these complications especially the 
brain abscess in patients of TOF. The early detection 
and prompt treatment of these patients will help in 
reducing the mortality and morbidity in them.
MATERIAL AND METHODS
It was a descriptive cross-sectional study done at the 
Pediatric Cardiology and Pediatric Neurology Depart-
ments of The Children’s Hospital and Institute of Child 
Health, Lahore from Dec 2009 to Nov 2010. Total 75 
unoperted echocardiographically proven cases of tetralogy
of fallot up to the age of 15 years presented with 
neurological manifestation were included in this study.
Patients are said to have neurological manifestation if 
they exhibit any one of the following i.e. persistent 
headache, unexplained recurrent vomiting, seizures, 
altered sensorium, hemeparesis, hemeplegia, aphasia,
cranial nerve involvement, nystagmus, ataxia, dysmetria 
or papilloedema on history and clinical examination. 
Patients presented with spell or operated for 
Blalock-Taussing shunt or primary repair were excluded 
from study. After taking informed consent by parents’ 
demographic data including age, gender and address 
were recorded on pre-designed Proforma. CT Brain with 
contrast was conducted in all these patients to look for 
cerebrovascular accident (hypodense non enhancing 
lesion) and brain abscess (hypodense ring enhancing 
focal lesion). The data was analyzed using SPSS v. 
12.0. A quantitative variable like age was presented by 
calculating mean and standard deviation. Qualitative 
variables like gender, cerebrovascular accident and 
brain abscess were presented by calculating frequencies 
and percentages.
RESULTS
Out of total 75 patients of Tetralogy of Fallot (TOF) 
presented with neurological manifestation 48 (64%) 
were having brain abscess, 24 (32%) were having 
cerebrovascular accident (CVA), 2 (2.6%) were having 
intracranial bleed and 1 (1.3%) was having 
meningoencephlitis (Table-1). Distribution of cases by 
age showed 14 cases (18.6%) were 0-2 years of ages 
of age, 7 cases (9.3%) were >2-5 years of age, 18 
cases (24%) were >5-10 years of age and 36 cases 
(48%) were >10-15 years of age with mean age of 
9.7±3 (Table–2). Disease breakdown of brain abscess 
according to age showed 3 cases (6.25%) were 0 – 2 
years of age, 4 cases (8.3%) were >2 – 5 years of age, 
11 cases (22.9%) were >5 – 10 years of age, and 30 
cases (62.5%) were >10 – 15 years of age with mean 
age of 10±3 years ( Table-2 ). Disease breakdown of 
cerebrovascular accident (CVA) according to age 
showed 13 cases (54%) were 0 – 2 years of age, 1 
cases (4.1%) were >2 – 5 years of age, 4 cases 
(16.6%) were >5 – 10 years of age, and 6 cases (25%) 
were >10 – 15 years of age with mean age of 4.7±3 
years ( Table-2 ). Distribution of cases by gender 
showed that 57 cases (76%) were male and 18 cases 
(24%) were female. Out of 48 cases of brain abscess 
38 (79.1%) were male and 10 (20.8%) were female. 
However among 24 cases of cerebrovascular accidents 
16 cases (66.6%) were male and 8 cases (33.3%) 
were female (Table-3).
DISCUSSION
Tetralogy of Fallot is a common cyanotic congenital 
heart disease, which occur in approximately 1 in 3600 
live birth and account for 3.5 % of infant born with 
congenital heart disease. It is diagnosed by 
echocardiography and characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (9). The clinical presentation of tetralogy of 
fallot depends upon the severity of right ventricular 
outflow tract obstruction (RVOTO). When severe at 
birth, there is duct dependant pulmonary circulation 
and prostaglandin E is required to maintain duct 
patency. Moderate RVOTO give rise to a systolic murmur 
in an asymptomatic child. Cyanosis usually develops 
between 6-8 month as infundibular stenosis increases 
producing right to left shunt (9).
Children of tetralogy of fallot are susceptible to serious 
neurological manifestation like brain abscess (Figure-I) 
and cerebrovascular accidents (stroke) which contribute 
significantly to mortality and morbidity in them (10, 11). 
The main contributing factors for brain abscess in these 
childrens are chronic hypoxia leading to polycythemia, 
poor host immunity and bypass of lung phagocytes (12). 
However the risk factors for stroke include 
polycythemia, anemia, prolonged hypotension and 
dehydration (10, 13, 14). Children with tetralogy of fallot are 
susceptible to two types of strokes i.e. arterial and 
venous. Venous thrombosis is more common than 
arterial thrombosis. CT scan brain is the first line 
investigation to detect these neurological complications 
especially in emergency (15). In developed countries 
these neurological manifestations like brain abscess 
and stroke are very rare and their main focus has been 
shifted to neurological complications of cardiac surgery 
in the very young children as result of cardiopulmonary 
bypass and total hypothermic circulatory arrest. 
However in developing countries many of congenital 
heart diseases including tetralogy of fallot remain 
uncorrected and these neurological complications are 
frequently encountered (10). The main reason behind it is 
the delay in surgery resulting in chronic hypoxia leading 
to secondary polycythemia which is responsible for these 
neurological complications. More recently, the Toronto 
group encountered that optimal age for elective primary 
repair of tetralogy of fallot patients should be 3 to 11 
months (16). In one study by Hirsh et al it was reported 
that primary repair of tetralogy of fallot if done in 
neonatal age will lead to no neurological complications 
(17). Gender distribution observed in my study showed 
male predominance which was also demonstrated by 
Aebi et al (18) and Carpenter et al (19). In our study we 
collected 75 unoperated cases of tetralogy of fallot up 
to the age of 15 years presented with neurological 
manifestation in a period of 12 months. This is a large 
number of patients collected from single hospital 
because The Children’s Hospital and Institute of Child 
Health, Lahore is a tertiary care hospital with facilities of 
pediatric cardiology, pediatric neurology and pediatric 
neurosurgery and patients being referred from all over 
country. Another important reason for this large number 
of unoperated patients of tetralogy of fallot with 
neurological complications is that chronic hypoxia (due 
to delay in surgery) is main etiological factor behind 
these neurological complications. This fact was also 
supported by Mulder et al who suggested by earlier 
repair of these children we can reduce duration of 
hypoxia in them (20). In our study 48 out of 75 patients 
(64%) were found to have brain abscess and 24 out of 
75 patients (32%) were found to have cerebrovascular 
accident (stroke) (Table-1). This is contrary to Bernstein 
D who suggested that brain abscess is less common 
than cerebrovascular accidents in children with tetralogy 
of fallot and extremely rare today (1). However our 
findings are comparable with another study of 
unoperated cases of tetralogy of fallot where incidence 
of brain abscesses in more than cerebrovascular 
accident (2). In this study 14 cases out of 75 (18.6%) 
were >2 year, 7 cases out of 75 (9.3%) were between 
>2 to 5 years, 18 cases out of 75 (24%) were between 
>5year to 10 years and 36 cases out of 75 (48%) were 
> 10 year of age. So it showed that the risk of 
neurological complications increase with increasing age 
in unoperated case of TOF. In children > 2 year of age, 
3 out of 14 cases were found to have brain abscess 
and 13 cases were found to have cerebrovascular 
accident, showing CVA is more common than brain 
abscess in this age group. However in children >10 
year of age 30 cases out of 36 cases were found to 
have brain abscess and 6 cases were of 
cerebrovascular accident revealing brain abscess is 
more common in this age group. (Table-2) So, in our 
study brain abscess in more common in children above 
2 year of age and cerebrovascular accident more 
common in children less than 2 year of age. This age 
distribution was also observed by Bernstein D (1). In this 
study the frequency of brain abscess increases with 
increasing age (Table-2). However cerebrovascular 
accident is common in two age groups i.e. less than 2 
years (54%) and more than 10 year (25%). The reason 
for increased number of brain abscess than 
cerebrovascular accident in our study seems to be due 
to delay in their surgery in developing country like 
Pakistan, malnutrition leading to impaired host 
immunity, and very late presentation of unoperated 
tetralogy of fallot as most of cases are above 10 years 
of age. The early diagnosis of brain abscess is very 
important because prompt management can decrease 
mortality and morbidity in them (5, 6). It was reported that 
advent of CT scan brain resulted in fourfold decrease in 
mortality of patients of tetralogy of fallot with brain 
abscess (7, 8). In developing country like Pakistan where 
CT facility is not available everywhere it is judicial to 
start intravenous antibiotic for every patient of tetralogy 
of fallot presented with neurological manifestation until 
it is get ruled out by CT brain with contrast because 
prompt treatment of brain abscess  can reduce fatal 
outcomes and improve prognosis in these children.
CONCLUSION
Brain abscess and cerebrovascular accidents are common 
neurological complications in unoperated children of 
Tetralogy of Fallot which are responsible for mortality 
and morbidity in them. Frequency of brain abscess is 
found to be more than cerebrovascular accidents in 
these patients. So we should have a high index of 
suspicion of these neurological complications especially 
of brain abscess in every unoperated patient of Tetralogy 
of Fallot presented with neurological manifestation. 
Early detection of cerebrovascular accident prevents 
further such episodes, and prompt diagnosis and 
treatment of brain abscess lead to better outcome.
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ENCEPHALOPATHY WITH BEHAVIORAL AND PSYCHIATRIC 
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ABSTRACT
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is associated with psychiatric symptoms, 
memory disturbances, seizures, dyskinesia, and catatonia along with other constellation of symptoms. It is more 
common in females and usually associated with underlying ovarian teratoma. Treatment involves immunosuppression. 
This is the first antibody proven case from Pakistan. Case Report: A 16 year old girl with a short history of sore throat 
and no other prior illness, presented with 12 day history of behavioral changes (can you please describe some 
behavioral changes?) and seizures, followed by decreased responsiveness, involuntary limb movements and facial 
grimacing. She also had intermittent high grade fever for 3 days. On examination she had spontaneous eye opening 
with continuous involuntary oro buccal and lingual movements. CT/MRI brain was normal. Spinal tap showed increased 
WBCs with lymphocytic predominance. EEG showed severe diffuse encephalopathy with no clear epileptiform 
discharges. HSV PCR came out to be negative. She was treated with Ceftriaxone, Acyclovir, Ampicillin, Vancomycin, 
Phenytoin and Levetiracetam. Acyclovir was later stopped after negative HSV PCR results. On suspicion of non 
infectious (autoimmune) encephalitis, treatment with IVIg was started and serum anti NMDA receptor antibodies were 
sent, which came out to be positive. Ultrasound pelvis showed no teratoma. Parents on follow up reported gradual 
resolution of symptoms and resumption of usual activities. Conclusion: Anti NMDA receptor encephalitis is associated 
with anti NMDA receptor antibodies is responsive to autoimmune treatment.
INTRODUCTION
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis 
associated with anti NMDA receptor antibodies is more
common in females and usually associated with 
underlying ovarian teratoma (1). Patients may present 
with a constellation of symptoms including psychiatric 
symptoms (2), memory disturbances, seizures, dyskinesia 
and catatonia. Treatment involves immuno suppression. A 
Pub-med search did not reveal any previous case of anti 
NMDA receptor encephalitis published from Pakistan. 
CASE REPORT
We report the case of a previously healthy16 year old 
girl with a short history of sore throat preceding the 
illness and  a 12 day history of behavioral changes and
seizures, followed by decreased responsiveness, 
involuntary limb movements, with facial grimacing. and
intermittent high grade fever for 3 days. she had 
received treatment for acute bacterial/viral meningitis 
with no improvement and was then shifted to our hospital. 
On examination, she was intubated, had spontaneous 
eye opening with continuous involuntary oro buccal and 
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lingual movements. Her blood pressure was 120/70 
mm of Hg; pulse was 110 beats/min with temperature 
of 102O F. There were no signs of meningeal irritation. 
workup showed normal chemistries with Na-149, 
K-3.2, Cr-0.67 and almost normal blood count, with 
WBCs-11000, Hb-10.17 and platelet count of 
223000.  ICT malaria and dengue serology were negative. 
CT/MRI brain was normal (Figure 1). Spinal tap showed 
increased WBCs with lymphocytic predominance 
(90%), proteins-25.6 and glucose-69. EEG showed 
severe diffuse encephalopathy with no clear epilepti-
form discharges (Figure 2). She was continued on I/V 
Ceftriaxone 2 gm BD, Acyclovir 750 mg TDS, Ampicillin 
2 gm 6 hourly, Vancomycin 1 gm BD, Phenytoin 100 
mg TDS and Levetiracetam 750 mg BD. CSF HSV PCR 
came out to be negative, so Acyclovir was stopped.  
Autoimmune work up including ANA, AMA, and ASMA 
came out negative. 
On suspicion of non herpetic (autoimmune) encephalitis, 
she was given IVIg for 5 days and serum anti NMDA 
receptor antibodies were sent, which came out. 
Ultrasound pelvis showed no teratoma. She was 
discharged and advised proper nursing care and 
rehabilitation. Parents on telephonic follow up reported 
that her symptoms had resolved gradually and she had 
resumed usual activities.
DISCUSSION
Anti-NMDA receptor encephalitis is a neuroimmune 
syndrome with autoantibodies recognizing extracellular 
epitopes in NR1/NR2 heteromers of NMDA receptor (3), 
and attenuating NMDA receptor function through its 
internalization (4). Reduction in NMDA receptor activity 
results in inactivation of GABAergic neurons, causing 
disinhibition of excitatory pathways leading to  fronto- 
striatal syndrome which may manifest as psychosis, 
catatonia, mutism, rigidity and dystonia or affecting the 
brainstem that may cause  semi-rhythmic limb, trunk 
and bulbar movements. Autonomic instability, with 
hyperthermia, hypoventilation, blood pressure 
fluctuations, tachycardia, bradycardia, constipation or 
ileus may also occur due to involvement of 
dopaminergic, noradrenergic and cholinergic systems (5, 7). 
Anti-NMDA receptor encephalitis is more common in 
females (80%) with 23 years as median age of 
presentation and association with underlying ovarian 
teratoma in approximately half of the cases. Patients 
present with schizophrenia like psychiatric symptoms, 
usually preceded by fever, headache, or viral 
infection-like illness. After reaching the peak of 
psychosis, most patients develop memory problems, 
seizures, unresponsive/ catatonic state, decreased 
consciousness, orofacial-limb dyskinesias, autonomic 
instability and hypoventilation, with 88% of patients 
requiring intensive care support usually (5, 8, 9). This 
disorder is usually severe and can be fatal, but it is 
potentially reversible. Once patients recover from the 
hyperkinetic phase, gradual improvement is expected 
within months with  full recovery over 3 or more years. 
Recognition of symptom complex is the key to 
diagnosis. Brain MRI is  unremarkable in 50% of the 
cases. If abnormal, it usually shows increased signals in 
FLAIR and T2 sequences in cerebral, cerebellar or 
medial temporal lobes (9). CSF reveals nonspecific 
As our patient had no previous history of MS, it was 
difficult to differentiate it from other varieties of 
malignant demyelinating diseases especially ADEM. 
However, historical data, CSF analysis and radiographic 
characteristics of lesions suggested fulminant MS 
(table 2) (20). Radiological images were almost diagnostic 
of tumefactive demyelinating process based on size 
(2cm or more), location (periventricular and juxtacortical) 
and nature of lesions (confluent areas, mixed T2 
weighted iso and hyperintensity of enhanced regions, 
absence of cortical involvement and absence of a mass 
effect) (14,15,21,22) The lesions can be multifocal (83%) 
(as in our case) or unifocal (17%)(13) CSF analysis in our 
patient revealed absence of pleocytosis with elevated 
protein and presence of oligoclonal bands which is 
present in 11% to 33% of tumefactive MS cases,(13) 
favouring our diagnosis of tumefactive MS over ADEM. (23) 
Biopsy of the lesions is not routinely recommended to 
make a histological diagnosis. Standard treatment 
approach for fulminant MS variants is similar to severe 
relapses of MS. However, due to the rarity and high 
mortality associated with Marburg variant of MS, only a 
limited number of case reports  have shown some 
promising results for Plasma exchange and Mitoxantrone 
as treatment for acute phase and prevention of further 
relapses (4,5,24) There is one published study of 
Fulminant MS from Pakistan also from our centre where 
patients were treated with IV immunoglobulins followed 
by Mitoxantrone, with good outcomes(22).
Fig 4.  Follow up of patient in neurology clinic 3 months 
later.
We used Plasma exchange (PLEX) in this patient due to 
financial constraints. Mitoxantrone is an immun- 
omodulatory agent used as a disease modifying drug 
(DMD) to improve neurological disability and delay 
progression in relapsing remitting MS and secondary 
progressive MS (21). Several randomized clinical trials 
used 12mg/m2 dose administered once every 3 
months (21). We have previously used mitoxantrone for 
management of relapsing remitting MS (23) and as a 
DMD for Fulminant MS.22 Though FMS is a disease of 
severe morbidity and high mortality but better outcome 
can be expected if treated promptly and aggressively 
with disease modifying therapies early in the course of 
the disease.
CONCLUSION
Due to limitation of resources in our country, PLEX 
followed by Mitoxantrone may be a valuable option for 
treatment of fulminant multiple sclerosis.
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changes (11). EEG often reveals diffuse delta slowing 
without paroxysmal discharges (1, 2). Detection of NMDA 
receptor antibody in CSF or serum is helpful in making 
the diagnosis (3). Treatment is focused on tumor
resection and immunotherapy (corticosteroids, plasma 
exchange, intravenous immunoglobulin). In non- 
responders, second-line immunotherapy (rituximab or
cyclophosphamide or combined) is required. Recovery 
may also occur spontaneously. More than 75% of the 
patients recover completely or have mild sequelae,
while remaining  end up with  disability or death (12, 13).
CONCLUSION
Anti-NMDA receptor encephalitis has a recognizable 
pattern of presentation that may mimic psychiatric and 
infective diseases and if diagnosed correctly can be
effectively treated.
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Figure 1. No significant intracranial abnormality noted
on MRI brain with no significant contrast enhancement
(A. T1WI, B.T1WI post contrast, C. FLAIR,D. T2WI)
came to be negative for malignancy. ANA was not done.
Patient showed gradual improvement in his clinical 
status and was discharged home 12 days later. He was 
given IV Mitoxantrone (12mg/m2), first dose given on 12 
day post admission and then once every 3 months. 
On discharge, EDSS improved from 9 to 5. He was 
followed in neurology clinic 3 months later with repeat 
MR imaging which showed interval regression in the size 
of previously noted lesions with no new activity (Fig.3). 
He showed remarkable clinical improvement, walking 
without support (EDSS 2) (Fig.4). He had no further 
relapse at 3 months.
DISCUSSION
Multiple sclerosis is the most common, idiopathic, 
inflammatory demyelinating disease of central nervous
system with a relapsing and remitting course (1)
Approximately 7% of patients may present with a 
fulminant disease (10). Tumefactive multiple sclerosis 
refers to large demyelinating lesions, typically 2 cm or 
larger in size, with surrounding mass effect, perilesional 
edema and open ring enhancement on gadolinium 
contrast (11,12,13). 
Figure 1. Axial diffusion weighted images(DWI) of Brain
(A) and (C) showing multiple nodular lesions of diffusion
restriction in bilateral parietal periventricular and 
subcortical regions, corresponding ADC images (B) 
and pons (D), largest one measuring 2.7×1.4 cm2.
They are iso-intense/hypointense on T1 (E) with subtle 
peripheral contrast enhancement (F) and correspondingly 
bright on FLAIR image with surrounding halo (G) and no 
significant mass effect.
First described nearly a century ago, Marburg variant of 
MS is a rare, acute, monophasic and highly aggressive 
form of MS, leading to severe morbidity or mortality 
within a few weeks to months.1 Due to its atypical 
clinical and radiographic features, it poses significant 
diagnostic dilemma (14). It presents with a polysymptomatic, 
monophasic illness (15) suggesting diffuse and extensive 
CNS involvement. 
Figure 2. Follow up MR images obtained 10 days later 
with new onset right hemiparesis and acute confusional 
state. DWI (A and C), ADC (B and D)and axial FLAIR 
images(E) showing development of new lesions and 
interval increase in size of previously observed multiple  
lesions which have become more confluent bilaterally.
Unlike classical MS, lesions occur simultaneously in all 
affected areas with large zones of confluent 
demyelination,(1,16) including cerebral hemisp- heres 
and brainstem (17) High mortality is associated with this 
variant especially with involvement of brainstem 
structures, (12,18,19) necessitating intensive care for 
aggressive management (15).First presentation of an 
acute, fulminant demyelinating event is the most 
common presentation in the course of tumefactive 
MS,13 hence early and prompt recognition of disease 
process and exclusion of infective, neoplastic, vasculitic and 
granulomatous disorder is of paramount importance.
Figure 3. Follow up MR images of same patient 
obtained at 3 months after resolution of acute neurological 
dysfunction. Axial T1 pre (A), post contrast (B) and FLAIR 
(C) images showing regression in size of previously noted 
lesions with no abnormal post contrast enhancement.
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INTRODUCTION
Tetralogy of Fallot (TOF) is a most common cyanotic 
congenital heart disease characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (1). Children with TOF are susceptible to serious 
neurological complications like cerebrovascular accidents 
(stroke) and brain abscess, which are mainly responsible 
for mortality and morbidity in these patients (1, 3). The 
incidence of cerebrovascular accidents and brain 
abscess in patients with TOF has been documented in 
Western literature as 8.6% and 13.7% respectively 2. 
Cerebrovascular accident is more common in children 
less than 2 years of age while brain abscess usually 
occur above 2 years of age. Brain abscess is a life 
threatening infection of brain parenchyma, but it is less 
common than cerebrovascular accidents because most 
patients of TOF are repaired at younger age (1). The 
extent of the neurological deficit depends largely upon 
the early detection of these complications. The early 
diagnosis of cerebrovascular accidents is important to 
prevent further recurrences (4), while the early detection 
of brain abscess is helpful for prompt management (5, 6). 
The advent of CT scan has resulted in fourfold decrease 
in mortality in these patients due to prompt identification 
and early intervention (7, 8). We observed that unlike 
developed countries, in developing countries like 
Pakistan children with TOF are more susceptible to 
adverse neurological complications especially the brain 
abscess due to delay in the surgical repair of TOF. 
To-date limited data is available regarding the frequency
of these complications in children with TOF. We 
speculated that by documenting the frequencies of 
these neurological complications, we can have high 
index of suspicion of these complications especially the 
brain abscess in patients of TOF. The early detection 
and prompt treatment of these patients will help in 
reducing the mortality and morbidity in them.
MATERIAL AND METHODS
It was a descriptive cross-sectional study done at the 
Pediatric Cardiology and Pediatric Neurology Depart-
ments of The Children’s Hospital and Institute of Child 
Health, Lahore from Dec 2009 to Nov 2010. Total 75 
unoperted echocardiographically proven cases of tetralogy
of fallot up to the age of 15 years presented with 
neurological manifestation were included in this study.
Patients are said to have neurological manifestation if 
they exhibit any one of the following i.e. persistent 
headache, unexplained recurrent vomiting, seizures, 
altered sensorium, hemeparesis, hemeplegia, aphasia,
cranial nerve involvement, nystagmus, ataxia, dysmetria 
or papilloedema on history and clinical examination. 
Patients presented with spell or operated for 
Blalock-Taussing shunt or primary repair were excluded 
from study. After taking informed consent by parents’ 
demographic data including age, gender and address 
were recorded on pre-designed Proforma. CT Brain with 
contrast was conducted in all these patients to look for 
cerebrovascular accident (hypodense non enhancing 
lesion) and brain abscess (hypodense ring enhancing 
focal lesion). The data was analyzed using SPSS v. 
12.0. A quantitative variable like age was presented by 
calculating mean and standard deviation. Qualitative 
variables like gender, cerebrovascular accident and 
brain abscess were presented by calculating frequencies 
and percentages.
RESULTS
Out of total 75 patients of Tetralogy of Fallot (TOF) 
presented with neurological manifestation 48 (64%) 
were having brain abscess, 24 (32%) were having 
cerebrovascular accident (CVA), 2 (2.6%) were having 
intracranial bleed and 1 (1.3%) was having 
meningoencephlitis (Table-1). Distribution of cases by 
age showed 14 cases (18.6%) were 0-2 years of ages 
of age, 7 cases (9.3%) were >2-5 years of age, 18 
cases (24%) were >5-10 years of age and 36 cases 
(48%) were >10-15 years of age with mean age of 
9.7±3 (Table–2). Disease breakdown of brain abscess 
according to age showed 3 cases (6.25%) were 0 – 2 
years of age, 4 cases (8.3%) were >2 – 5 years of age, 
11 cases (22.9%) were >5 – 10 years of age, and 30 
cases (62.5%) were >10 – 15 years of age with mean 
age of 10±3 years ( Table-2 ). Disease breakdown of 
cerebrovascular accident (CVA) according to age 
showed 13 cases (54%) were 0 – 2 years of age, 1 
cases (4.1%) were >2 – 5 years of age, 4 cases 
(16.6%) were >5 – 10 years of age, and 6 cases (25%) 
were >10 – 15 years of age with mean age of 4.7±3 
years ( Table-2 ). Distribution of cases by gender 
showed that 57 cases (76%) were male and 18 cases 
(24%) were female. Out of 48 cases of brain abscess 
38 (79.1%) were male and 10 (20.8%) were female. 
However among 24 cases of cerebrovascular accidents 
16 cases (66.6%) were male and 8 cases (33.3%) 
were female (Table-3).
DISCUSSION
Tetralogy of Fallot is a common cyanotic congenital 
heart disease, which occur in approximately 1 in 3600 
live birth and account for 3.5 % of infant born with 
congenital heart disease. It is diagnosed by 
echocardiography and characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (9). The clinical presentation of tetralogy of 
fallot depends upon the severity of right ventricular 
outflow tract obstruction (RVOTO). When severe at 
birth, there is duct dependant pulmonary circulation 
and prostaglandin E is required to maintain duct 
patency. Moderate RVOTO give rise to a systolic murmur 
in an asymptomatic child. Cyanosis usually develops 
between 6-8 month as infundibular stenosis increases 
producing right to left shunt (9).
Children of tetralogy of fallot are susceptible to serious 
neurological manifestation like brain abscess (Figure-I) 
and cerebrovascular accidents (stroke) which contribute 
significantly to mortality and morbidity in them (10, 11). 
The main contributing factors for brain abscess in these 
childrens are chronic hypoxia leading to polycythemia, 
poor host immunity and bypass of lung phagocytes (12). 
However the risk factors for stroke include 
polycythemia, anemia, prolonged hypotension and 
dehydration (10, 13, 14). Children with tetralogy of fallot are 
susceptible to two types of strokes i.e. arterial and 
venous. Venous thrombosis is more common than 
arterial thrombosis. CT scan brain is the first line 
investigation to detect these neurological complications 
especially in emergency (15). In developed countries 
these neurological manifestations like brain abscess 
and stroke are very rare and their main focus has been 
shifted to neurological complications of cardiac surgery 
in the very young children as result of cardiopulmonary 
bypass and total hypothermic circulatory arrest. 
However in developing countries many of congenital 
heart diseases including tetralogy of fallot remain 
uncorrected and these neurological complications are 
frequently encountered (10). The main reason behind it is 
the delay in surgery resulting in chronic hypoxia leading 
to secondary polycythemia which is responsible for these 
neurological complications. More recently, the Toronto 
group encountered that optimal age for elective primary 
repair of tetralogy of fallot patients should be 3 to 11 
months (16). In one study by Hirsh et al it was reported 
that primary repair of tetralogy of fallot if done in 
neonatal age will lead to no neurological complications 
(17). Gender distribution observed in my study showed 
male predominance which was also demonstrated by 
Aebi et al (18) and Carpenter et al (19). In our study we 
collected 75 unoperated cases of tetralogy of fallot up 
to the age of 15 years presented with neurological 
manifestation in a period of 12 months. This is a large 
number of patients collected from single hospital 
because The Children’s Hospital and Institute of Child 
Health, Lahore is a tertiary care hospital with facilities of 
pediatric cardiology, pediatric neurology and pediatric 
neurosurgery and patients being referred from all over 
country. Another important reason for this large number 
of unoperated patients of tetralogy of fallot with 
neurological complications is that chronic hypoxia (due 
to delay in surgery) is main etiological factor behind 
these neurological complications. This fact was also 
supported by Mulder et al who suggested by earlier 
repair of these children we can reduce duration of 
hypoxia in them (20). In our study 48 out of 75 patients 
(64%) were found to have brain abscess and 24 out of 
75 patients (32%) were found to have cerebrovascular 
accident (stroke) (Table-1). This is contrary to Bernstein 
D who suggested that brain abscess is less common 
than cerebrovascular accidents in children with tetralogy 
of fallot and extremely rare today (1). However our 
findings are comparable with another study of 
unoperated cases of tetralogy of fallot where incidence 
of brain abscesses in more than cerebrovascular 
accident (2). In this study 14 cases out of 75 (18.6%) 
were >2 year, 7 cases out of 75 (9.3%) were between 
>2 to 5 years, 18 cases out of 75 (24%) were between 
>5year to 10 years and 36 cases out of 75 (48%) were 
> 10 year of age. So it showed that the risk of 
neurological complications increase with increasing age 
in unoperated case of TOF. In children > 2 year of age, 
3 out of 14 cases were found to have brain abscess 
and 13 cases were found to have cerebrovascular 
accident, showing CVA is more common than brain 
abscess in this age group. However in children >10 
year of age 30 cases out of 36 cases were found to 
have brain abscess and 6 cases were of 
cerebrovascular accident revealing brain abscess is 
more common in this age group. (Table-2) So, in our 
study brain abscess in more common in children above 
2 year of age and cerebrovascular accident more 
common in children less than 2 year of age. This age 
distribution was also observed by Bernstein D (1). In this 
study the frequency of brain abscess increases with 
increasing age (Table-2). However cerebrovascular 
accident is common in two age groups i.e. less than 2 
years (54%) and more than 10 year (25%). The reason 
for increased number of brain abscess than 
cerebrovascular accident in our study seems to be due 
to delay in their surgery in developing country like 
Pakistan, malnutrition leading to impaired host 
immunity, and very late presentation of unoperated 
tetralogy of fallot as most of cases are above 10 years 
of age. The early diagnosis of brain abscess is very 
important because prompt management can decrease 
mortality and morbidity in them (5, 6). It was reported that 
advent of CT scan brain resulted in fourfold decrease in 
mortality of patients of tetralogy of fallot with brain 
abscess (7, 8). In developing country like Pakistan where 
CT facility is not available everywhere it is judicial to 
start intravenous antibiotic for every patient of tetralogy 
of fallot presented with neurological manifestation until 
it is get ruled out by CT brain with contrast because 
prompt treatment of brain abscess  can reduce fatal 
outcomes and improve prognosis in these children.
CONCLUSION
Brain abscess and cerebrovascular accidents are common 
neurological complications in unoperated children of 
Tetralogy of Fallot which are responsible for mortality 
and morbidity in them. Frequency of brain abscess is 
found to be more than cerebrovascular accidents in 
these patients. So we should have a high index of 
suspicion of these neurological complications especially 
of brain abscess in every unoperated patient of Tetralogy 
of Fallot presented with neurological manifestation. 
Early detection of cerebrovascular accident prevents 
further such episodes, and prompt diagnosis and 
treatment of brain abscess lead to better outcome.
REFERRENCES
1.    Bermstein D. Congenital heart disease. In: Kleigman 
      MR, Behrman ER, Janson BH, Stanton FB. Nelson 
      textbook of pediatrics. 18th ed. New Delhi: Elsevier; 
      2008. p. 1906-11.
2.    Sadiq A, Shymkrishnan GK, Theodore S, 
      Gopalkarishnan S, Tharakan MJ, Karunkaran J. Long 
      term functional assessment after correction of 
      tetralogy of fallot in adulthood. Ann Thorac 
      Surg 2007;83:1790-5.
3.    Engelfreit P, Boersma E, Oechslin E, Tijssen J, 
      Gatzoulis AM, Thilen U, et al. The spectrum of adult 
      congenital heart disease in Europe: morbidity and 
      mortality in a 5 year follow up period. Eur Heart J 
      2005;26:2325-33.
4.    Saliha MA, Al-Jarallah AS, Abdel-Gader AG, 
      Al-Jarallah AA, Al-Saadi MM, Kentab AY, et al. 
      Cardiac diseases a risk factor for stroke in Saudi 
      children. Saudi Med J 2006;27:S61-8.
5.    Mehnaz A, Syed UM, Saleem SA, Khalid NS. Clinical 
      features and outcome of cerebral abscesses in 
      congenital heart disease. J Ayub Med Coll Abbottabad 
      2006;18:21-4.
6.    Kanamori S, Kusano N, Shinzato T, Saito A. The role 
      of the capsule of the Streptococcus milleri group in 
      its pathogenicity. J Infect Chemother 2004;10:105-9.
7.    Benardini GL. Diagnosis and management of brain 
     abscess and subdural empyema. Curr Neurol 
      Neurosci Rep 2004;4:448-56.
8.    Morthy, Rajshaker VB. Isolated ring enhancing lesion 
      of brain abscess in patient with cyanotic heart 
      disease: role of stereotactic intervention. Neurol 
      India 2008;51:400-4.
9.    Shinebourne AE, Babu-Narayan VS, Carvalho SJ. 
      Tetraloy of fallot: from fetus to adult. Heart 
      2006 September;92(9):1353-1359.
10.  Kumar K. Neurological complications of congenital 
      heart disease. Indian J Pedaitr 2000 March:67 
      (3suppl):S 15-9.
11.  Bhatnagar S, Naware S, Kuber R, Thind SS. Pediatric 
      stroke: Neurological sequel in uncorrected tetralogy 
      of fallot. Ann Med Health Sci Res 2013 November; 3 
      (suppl1:S27-S30.
12.  Raha A, Ganjoo P, Singh A, Tandon SM, Singh D. 
      Surgery for brain abscess in children with cyanotic 
      heart diseases: An anesthetic challenge. J Pediatr 
      Neurosci 2012 Jan-Apr; 7(1):23-26.
13.  Carvalho KS, Garg BP. Arterial strokes in children. 
      Neurol clin 2002;20:1079-100.
14.  Rose SS, Shah AA, Hoover DR, Saidi P. Cyanotic 
      congenital heart disease (CCHD) with symptomatic 
      erythrocytosis. J Gen Intern Med 2007;22:1775-7.
15.  Dai AL. Paediatric cerebral venous thrombosis. J Pak 
      Med Assoc 2006;56:531-5.
16.  Van Arsdell GS, Maharaj GS, Tom J. What is the 
      optimal age for repair of tetralogy of fallot ? Circulation 
      2000.102lll123-lll129.III129.
17.  Hirsch JC, Mosca RS, Bore EL. Complete repair of 
      tetralogy of fallot in neonate: results in modern era. 
      Ann surg 2000. 232508-514.514.
18.  Aebi C, Kaufmann F, Schaad UB. Brain abscess in 
      childhood: Long term experiences. Eur J Pediatr 
      1991;150:282-6.
19.  Carpenter J, Stapleton S, Holliman R. Retrospective 
      analysis of 49 cases of brain abscess and review of 
      the literature. Eur J Clin Microbiol Infect Dis 2007; 
      26:1-11.
20.  Mulder TJ, Pyles LA, Stolfi A. A multicenter analysis 
      of the choice of initial surgical procedure in tetralogy 
      of fallot. Pediatr Cardiol 2002;23:580-6.
INTRODUCTION
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis 
associated with anti NMDA receptor antibodies is more
common in females and usually associated with 
underlying ovarian teratoma (1). Patients may present 
with a constellation of symptoms including psychiatric 
symptoms (2), memory disturbances, seizures, dyskinesia 
and catatonia. Treatment involves immuno suppression. A 
Pub-med search did not reveal any previous case of anti 
NMDA receptor encephalitis published from Pakistan. 
CASE REPORT
We report the case of a previously healthy16 year old 
girl with a short history of sore throat preceding the 
illness and  a 12 day history of behavioral changes and
seizures, followed by decreased responsiveness, 
involuntary limb movements, with facial grimacing. and
intermittent high grade fever for 3 days. she had 
received treatment for acute bacterial/viral meningitis 
with no improvement and was then shifted to our hospital. 
On examination, she was intubated, had spontaneous 
eye opening with continuous involuntary oro buccal and 
lingual movements. Her blood pressure was 120/70 
mm of Hg; pulse was 110 beats/min with temperature 
of 102O F. There were no signs of meningeal irritation. 
workup showed normal chemistries with Na-149, 
K-3.2, Cr-0.67 and almost normal blood count, with 
WBCs-11000, Hb-10.17 and platelet count of 
223000.  ICT malaria and dengue serology were negative. 
CT/MRI brain was normal (Figure 1). Spinal tap showed 
increased WBCs with lymphocytic predominance 
(90%), proteins-25.6 and glucose-69. EEG showed 
severe diffuse encephalopathy with no clear epilepti-
form discharges (Figure 2). She was continued on I/V 
Ceftriaxone 2 gm BD, Acyclovir 750 mg TDS, Ampicillin 
2 gm 6 hourly, Vancomycin 1 gm BD, Phenytoin 100 
mg TDS and Levetiracetam 750 mg BD. CSF HSV PCR 
came out to be negative, so Acyclovir was stopped.  
Autoimmune work up including ANA, AMA, and ASMA 
came out negative. 
On suspicion of non herpetic (autoimmune) encephalitis, 
she was given IVIg for 5 days and serum anti NMDA 
receptor antibodies were sent, which came out. 
Ultrasound pelvis showed no teratoma. She was 
discharged and advised proper nursing care and 
rehabilitation. Parents on telephonic follow up reported 
that her symptoms had resolved gradually and she had 
resumed usual activities.
DISCUSSION
Anti-NMDA receptor encephalitis is a neuroimmune 
syndrome with autoantibodies recognizing extracellular 
epitopes in NR1/NR2 heteromers of NMDA receptor (3), 
and attenuating NMDA receptor function through its 
internalization (4). Reduction in NMDA receptor activity 
results in inactivation of GABAergic neurons, causing 
disinhibition of excitatory pathways leading to  fronto- 
striatal syndrome which may manifest as psychosis, 
catatonia, mutism, rigidity and dystonia or affecting the 
brainstem that may cause  semi-rhythmic limb, trunk 
and bulbar movements. Autonomic instability, with 
hyperthermia, hypoventilation, blood pressure 
fluctuations, tachycardia, bradycardia, constipation or 
ileus may also occur due to involvement of 
dopaminergic, noradrenergic and cholinergic systems (5, 7). 
Anti-NMDA receptor encephalitis is more common in 
females (80%) with 23 years as median age of 
presentation and association with underlying ovarian 
teratoma in approximately half of the cases. Patients 
present with schizophrenia like psychiatric symptoms, 
usually preceded by fever, headache, or viral 
infection-like illness. After reaching the peak of 
psychosis, most patients develop memory problems, 
seizures, unresponsive/ catatonic state, decreased 
consciousness, orofacial-limb dyskinesias, autonomic 
instability and hypoventilation, with 88% of patients 
requiring intensive care support usually (5, 8, 9). This 
disorder is usually severe and can be fatal, but it is 
potentially reversible. Once patients recover from the 
hyperkinetic phase, gradual improvement is expected 
within months with  full recovery over 3 or more years. 
Recognition of symptom complex is the key to 
diagnosis. Brain MRI is  unremarkable in 50% of the 
cases. If abnormal, it usually shows increased signals in 
FLAIR and T2 sequences in cerebral, cerebellar or 
medial temporal lobes (9). CSF reveals nonspecific 
As our patient had no previous history of MS, it was 
difficult to differentiate it from other varieties of 
malignant demyelinating diseases especially ADEM. 
However, historical data, CSF analysis and radiographic 
characteristics of lesions suggested fulminant MS 
(table 2) (20). Radiological images were almost diagnostic 
of tumefactive demyelinating process based on size 
(2cm or more), location (periventricular and juxtacortical) 
and nature of lesions (confluent areas, mixed T2 
weighted iso and hyperintensity of enhanced regions, 
absence of cortical involvement and absence of a mass 
effect) (14,15,21,22) The lesions can be multifocal (83%) 
(as in our case) or unifocal (17%)(13) CSF analysis in our 
patient revealed absence of pleocytosis with elevated 
protein and presence of oligoclonal bands which is 
present in 11% to 33% of tumefactive MS cases,(13) 
favouring our diagnosis of tumefactive MS over ADEM. (23) 
Biopsy of the lesions is not routinely recommended to 
make a histological diagnosis. Standard treatment 
approach for fulminant MS variants is similar to severe 
relapses of MS. However, due to the rarity and high 
mortality associated with Marburg variant of MS, only a 
limited number of case reports  have shown some 
promising results for Plasma exchange and Mitoxantrone 
as treatment for acute phase and prevention of further 
relapses (4,5,24) There is one published study of 
Fulminant MS from Pakistan also from our centre where 
patients were treated with IV immunoglobulins followed 
by Mitoxantrone, with good outcomes(22).
Fig 4.  Follow up of patient in neurology clinic 3 months 
later.
We used Plasma exchange (PLEX) in this patient due to 
financial constraints. Mitoxantrone is an immun- 
omodulatory agent used as a disease modifying drug 
(DMD) to improve neurological disability and delay 
progression in relapsing remitting MS and secondary 
progressive MS (21). Several randomized clinical trials 
used 12mg/m2 dose administered once every 3 
months (21). We have previously used mitoxantrone for 
management of relapsing remitting MS (23) and as a 
DMD for Fulminant MS.22 Though FMS is a disease of 
severe morbidity and high mortality but better outcome 
can be expected if treated promptly and aggressively 
with disease modifying therapies early in the course of 
the disease.
CONCLUSION
Due to limitation of resources in our country, PLEX 
followed by Mitoxantrone may be a valuable option for 
treatment of fulminant multiple sclerosis.
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changes (11). EEG often reveals diffuse delta slowing 
without paroxysmal discharges (1, 2). Detection of NMDA 
receptor antibody in CSF or serum is helpful in making 
the diagnosis (3). Treatment is focused on tumor
resection and immunotherapy (corticosteroids, plasma 
exchange, intravenous immunoglobulin). In non- 
responders, second-line immunotherapy (rituximab or
cyclophosphamide or combined) is required. Recovery 
may also occur spontaneously. More than 75% of the 
patients recover completely or have mild sequelae,
while remaining  end up with  disability or death (12, 13).
CONCLUSION
Anti-NMDA receptor encephalitis has a recognizable 
pattern of presentation that may mimic psychiatric and 
infective diseases and if diagnosed correctly can be
effectively treated.
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Figure 2. No significant intracranial abnormality noted 
on MRI brain with no significant contrast enhancement 
(A. T1WI, B.T1WI post contrast, C. FLAIR, D. T2WI)
Figure 2. EEG showing severe diffuse encephalopathy
came to be negative for malignancy. ANA was not done.
Patient showed gradual improvement in his clinical 
status and was discharged home 12 days later. He was 
given IV Mitoxantrone (12mg/m2), first dose given on 12 
day post admission and then once every 3 months. 
On discharge, EDSS improved from 9 to 5. He was 
followed in neurology clinic 3 months later with repeat 
MR imaging which showed interval regression in the size 
of previously noted lesions with no new activity (Fig.3). 
He showed remarkable clinical improvement, walking 
without support (EDSS 2) (Fig.4). He had no further 
relapse at 3 months.
DISCUSSION
Multiple sclerosis is the most common, idiopathic, 
inflammatory demyelinating disease of central nervous
system with a relapsing and remitting course (1)
Approximately 7% of patients may present with a 
fulminant disease (10). Tumefactive multiple sclerosis 
refers to large demyelinating lesions, typically 2 cm or 
larger in size, with surrounding mass effect, perilesional 
edema and open ring enhancement on gadolinium 
contrast (11,12,13). 
Figure 1. Axial diffusion weighted images(DWI) of Brain
(A) and (C) showing multiple nodular lesions of diffusion
restriction in bilateral parietal periventricular and 
subcortical regions, corresponding ADC images (B) 
and pons (D), largest one measuring 2.7×1.4 cm2.
They are iso-intense/hypointense on T1 (E) with subtle 
peripheral contrast enhancement (F) and correspondingly 
bright on FLAIR image with surrounding halo (G) and no 
significant mass effect.
First described nearly a century ago, Marburg variant of 
MS is a rare, acute, monophasic and highly aggressive 
form of MS, leading to severe morbidity or mortality 
within a few weeks to months.1 Due to its atypical 
clinical and radiographic features, it poses significant 
diagnostic dilemma (14). It presents with a polysymptomatic, 
monophasic illness (15) suggesting diffuse and extensive 
CNS involvement. 
Figure 2. Follow up MR images obtained 10 days later 
with new onset right hemiparesis and acute confusional 
state. DWI (A and C), ADC (B and D)and axial FLAIR 
images(E) showing development of new lesions and 
interval increase in size of previously observed multiple  
lesions which have become more confluent bilaterally.
Unlike classical MS, lesions occur simultaneously in all 
affected areas with large zones of confluent 
demyelination,(1,16) including cerebral hemisp- heres 
and brainstem (17) High mortality is associated with this 
variant especially with involvement of brainstem 
structures, (12,18,19) necessitating intensive care for 
aggressive management (15).First presentation of an 
acute, fulminant demyelinating event is the most 
common presentation in the course of tumefactive 
MS,13 hence early and prompt recognition of disease 
process and exclusion of infective, neoplastic, vasculitic and 
granulomatous disorder is of paramount importance.
Figure 3. Follow up MR images of same patient 
obtained at 3 months after resolution of acute neurological 
dysfunction. Axial T1 pre (A), post contrast (B) and FLAIR 
(C) images showing regression in size of previously noted 
lesions with no abnormal post contrast enhancement.
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INTRODUCTION
Tetralogy of Fallot (TOF) is a most common cyanotic 
congenital heart disease characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (1). Children with TOF are susceptible to serious 
neurological complications like cerebrovascular accidents 
(stroke) and brain abscess, which are mainly responsible 
for mortality and morbidity in these patients (1, 3). The 
incidence of cerebrovascular accidents and brain 
abscess in patients with TOF has been documented in 
Western literature as 8.6% and 13.7% respectively 2. 
Cerebrovascular accident is more common in children 
less than 2 years of age while brain abscess usually 
occur above 2 years of age. Brain abscess is a life 
threatening infection of brain parenchyma, but it is less 
common than cerebrovascular accidents because most 
patients of TOF are repaired at younger age (1). The 
extent of the neurological deficit depends largely upon 
the early detection of these complications. The early 
diagnosis of cerebrovascular accidents is important to 
prevent further recurrences (4), while the early detection 
of brain abscess is helpful for prompt management (5, 6). 
The advent of CT scan has resulted in fourfold decrease 
in mortality in these patients due to prompt identification 
and early intervention (7, 8). We observed that unlike 
developed countries, in developing countries like 
Pakistan children with TOF are more susceptible to 
adverse neurological complications especially the brain 
abscess due to delay in the surgical repair of TOF. 
To-date limited data is available regarding the frequency
of these complications in children with TOF. We 
speculated that by documenting the frequencies of 
these neurological complications, we can have high 
index of suspicion of these complications especially the 
brain abscess in patients of TOF. The early detection 
and prompt treatment of these patients will help in 
reducing the mortality and morbidity in them.
MATERIAL AND METHODS
It was a descriptive cross-sectional study done at the 
Pediatric Cardiology and Pediatric Neurology Depart-
ments of The Children’s Hospital and Institute of Child 
Health, Lahore from Dec 2009 to Nov 2010. Total 75 
unoperted echocardiographically proven cases of tetralogy
of fallot up to the age of 15 years presented with 
neurological manifestation were included in this study.
Patients are said to have neurological manifestation if 
they exhibit any one of the following i.e. persistent 
headache, unexplained recurrent vomiting, seizures, 
altered sensorium, hemeparesis, hemeplegia, aphasia,
cranial nerve involvement, nystagmus, ataxia, dysmetria 
or papilloedema on history and clinical examination. 
Patients presented with spell or operated for 
Blalock-Taussing shunt or primary repair were excluded 
from study. After taking informed consent by parents’ 
demographic data including age, gender and address 
were recorded on pre-designed Proforma. CT Brain with 
contrast was conducted in all these patients to look for 
cerebrovascular accident (hypodense non enhancing 
lesion) and brain abscess (hypodense ring enhancing 
focal lesion). The data was analyzed using SPSS v. 
12.0. A quantitative variable like age was presented by 
calculating mean and standard deviation. Qualitative 
variables like gender, cerebrovascular accident and 
brain abscess were presented by calculating frequencies 
and percentages.
RESULTS
Out of total 75 patients of Tetralogy of Fallot (TOF) 
presented with neurological manifestation 48 (64%) 
were having brain abscess, 24 (32%) were having 
cerebrovascular accident (CVA), 2 (2.6%) were having 
intracranial bleed and 1 (1.3%) was having 
meningoencephlitis (Table-1). Distribution of cases by 
age showed 14 cases (18.6%) were 0-2 years of ages 
of age, 7 cases (9.3%) were >2-5 years of age, 18 
cases (24%) were >5-10 years of age and 36 cases 
(48%) were >10-15 years of age with mean age of 
9.7±3 (Table–2). Disease breakdown of brain abscess 
according to age showed 3 cases (6.25%) were 0 – 2 
years of age, 4 cases (8.3%) were >2 – 5 years of age, 
11 cases (22.9%) were >5 – 10 years of age, and 30 
cases (62.5%) were >10 – 15 years of age with mean 
age of 10±3 years ( Table-2 ). Disease breakdown of 
cerebrovascular accident (CVA) according to age 
showed 13 cases (54%) were 0 – 2 years of age, 1 
cases (4.1%) were >2 – 5 years of age, 4 cases 
(16.6%) were >5 – 10 years of age, and 6 cases (25%) 
were >10 – 15 years of age with mean age of 4.7±3 
years ( Table-2 ). Distribution of cases by gender 
showed that 57 cases (76%) were male and 18 cases 
(24%) were female. Out of 48 cases of brain abscess 
38 (79.1%) were male and 10 (20.8%) were female. 
However among 24 cases of cerebrovascular accidents 
16 cases (66.6%) were male and 8 cases (33.3%) 
were female (Table-3).
DISCUSSION
Tetralogy of Fallot is a common cyanotic congenital 
heart disease, which occur in approximately 1 in 3600 
live birth and account for 3.5 % of infant born with 
congenital heart disease. It is diagnosed by 
echocardiography and characterized by ventricular 
septal defect (VSD), overriding of aorta, obstruction to 
right ventricular outflow tract and hypertrophy of right 
ventricle (9). The clinical presentation of tetralogy of 
fallot depends upon the severity of right ventricular 
outflow tract obstruction (RVOTO). When severe at 
birth, there is duct dependant pulmonary circulation 
and prostaglandin E is required to maintain duct 
patency. Moderate RVOTO give rise to a systolic murmur 
in an asymptomatic child. Cyanosis usually develops 
between 6-8 month as infundibular stenosis increases 
producing right to left shunt (9).
Children of tetralogy of fallot are susceptible to serious 
neurological manifestation like brain abscess (Figure-I) 
and cerebrovascular accidents (stroke) which contribute 
significantly to mortality and morbidity in them (10, 11). 
The main contributing factors for brain abscess in these 
childrens are chronic hypoxia leading to polycythemia, 
poor host immunity and bypass of lung phagocytes (12). 
However the risk factors for stroke include 
polycythemia, anemia, prolonged hypotension and 
dehydration (10, 13, 14). Children with tetralogy of fallot are 
susceptible to two types of strokes i.e. arterial and 
venous. Venous thrombosis is more common than 
arterial thrombosis. CT scan brain is the first line 
investigation to detect these neurological complications 
especially in emergency (15). In developed countries 
these neurological manifestations like brain abscess 
and stroke are very rare and their main focus has been 
shifted to neurological complications of cardiac surgery 
in the very young children as result of cardiopulmonary 
bypass and total hypothermic circulatory arrest. 
However in developing countries many of congenital 
heart diseases including tetralogy of fallot remain 
uncorrected and these neurological complications are 
frequently encountered (10). The main reason behind it is 
the delay in surgery resulting in chronic hypoxia leading 
to secondary polycythemia which is responsible for these 
neurological complications. More recently, the Toronto 
group encountered that optimal age for elective primary 
repair of tetralogy of fallot patients should be 3 to 11 
months (16). In one study by Hirsh et al it was reported 
that primary repair of tetralogy of fallot if done in 
neonatal age will lead to no neurological complications 
(17). Gender distribution observed in my study showed 
male predominance which was also demonstrated by 
Aebi et al (18) and Carpenter et al (19). In our study we 
collected 75 unoperated cases of tetralogy of fallot up 
to the age of 15 years presented with neurological 
manifestation in a period of 12 months. This is a large 
number of patients collected from single hospital 
because The Children’s Hospital and Institute of Child 
Health, Lahore is a tertiary care hospital with facilities of 
pediatric cardiology, pediatric neurology and pediatric 
neurosurgery and patients being referred from all over 
country. Another important reason for this large number 
of unoperated patients of tetralogy of fallot with 
neurological complications is that chronic hypoxia (due 
to delay in surgery) is main etiological factor behind 
these neurological complications. This fact was also 
supported by Mulder et al who suggested by earlier 
repair of these children we can reduce duration of 
hypoxia in them (20). In our study 48 out of 75 patients 
(64%) were found to have brain abscess and 24 out of 
75 patients (32%) were found to have cerebrovascular 
accident (stroke) (Table-1). This is contrary to Bernstein 
D who suggested that brain abscess is less common 
than cerebrovascular accidents in children with tetralogy 
of fallot and extremely rare today (1). However our 
findings are comparable with another study of 
unoperated cases of tetralogy of fallot where incidence 
of brain abscesses in more than cerebrovascular 
accident (2). In this study 14 cases out of 75 (18.6%) 
were >2 year, 7 cases out of 75 (9.3%) were between 
>2 to 5 years, 18 cases out of 75 (24%) were between 
>5year to 10 years and 36 cases out of 75 (48%) were 
> 10 year of age. So it showed that the risk of 
neurological complications increase with increasing age 
in unoperated case of TOF. In children > 2 year of age, 
3 out of 14 cases were found to have brain abscess 
and 13 cases were found to have cerebrovascular 
accident, showing CVA is more common than brain 
abscess in this age group. However in children >10 
year of age 30 cases out of 36 cases were found to 
have brain abscess and 6 cases were of 
cerebrovascular accident revealing brain abscess is 
more common in this age group. (Table-2) So, in our 
study brain abscess in more common in children above 
2 year of age and cerebrovascular accident more 
common in children less than 2 year of age. This age 
distribution was also observed by Bernstein D (1). In this 
study the frequency of brain abscess increases with 
increasing age (Table-2). However cerebrovascular 
accident is common in two age groups i.e. less than 2 
years (54%) and more than 10 year (25%). The reason 
for increased number of brain abscess than 
cerebrovascular accident in our study seems to be due 
to delay in their surgery in developing country like 
Pakistan, malnutrition leading to impaired host 
immunity, and very late presentation of unoperated 
tetralogy of fallot as most of cases are above 10 years 
of age. The early diagnosis of brain abscess is very 
important because prompt management can decrease 
mortality and morbidity in them (5, 6). It was reported that 
advent of CT scan brain resulted in fourfold decrease in 
mortality of patients of tetralogy of fallot with brain 
abscess (7, 8). In developing country like Pakistan where 
CT facility is not available everywhere it is judicial to 
start intravenous antibiotic for every patient of tetralogy 
of fallot presented with neurological manifestation until 
it is get ruled out by CT brain with contrast because 
prompt treatment of brain abscess  can reduce fatal 
outcomes and improve prognosis in these children.
CONCLUSION
Brain abscess and cerebrovascular accidents are common 
neurological complications in unoperated children of 
Tetralogy of Fallot which are responsible for mortality 
and morbidity in them. Frequency of brain abscess is 
found to be more than cerebrovascular accidents in 
these patients. So we should have a high index of 
suspicion of these neurological complications especially 
of brain abscess in every unoperated patient of Tetralogy 
of Fallot presented with neurological manifestation. 
Early detection of cerebrovascular accident prevents 
further such episodes, and prompt diagnosis and 
treatment of brain abscess lead to better outcome.
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INTRODUCTION
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis 
associated with anti NMDA receptor antibodies is more
common in females and usually associated with 
underlying ovarian teratoma (1). Patients may present 
with a constellation of symptoms including psychiatric 
symptoms (2), memory disturbances, seizures, dyskinesia 
and catatonia. Treatment involves immuno suppression. A 
Pub-med search did not reveal any previous case of anti 
NMDA receptor encephalitis published from Pakistan. 
CASE REPORT
We report the case of a previously healthy16 year old 
girl with a short history of sore throat preceding the 
illness and  a 12 day history of behavioral changes and
seizures, followed by decreased responsiveness, 
involuntary limb movements, with facial grimacing. and
intermittent high grade fever for 3 days. she had 
received treatment for acute bacterial/viral meningitis 
with no improvement and was then shifted to our hospital. 
On examination, she was intubated, had spontaneous 
eye opening with continuous involuntary oro buccal and 
lingual movements. Her blood pressure was 120/70 
mm of Hg; pulse was 110 beats/min with temperature 
of 102O F. There were no signs of meningeal irritation. 
workup showed normal chemistries with Na-149, 
K-3.2, Cr-0.67 and almost normal blood count, with 
WBCs-11000, Hb-10.17 and platelet count of 
223000.  ICT malaria and dengue serology were negative. 
CT/MRI brain was normal (Figure 1). Spinal tap showed 
increased WBCs with lymphocytic predominance 
(90%), proteins-25.6 and glucose-69. EEG showed 
severe diffuse encephalopathy with no clear epilepti-
form discharges (Figure 2). She was continued on I/V 
Ceftriaxone 2 gm BD, Acyclovir 750 mg TDS, Ampicillin 
2 gm 6 hourly, Vancomycin 1 gm BD, Phenytoin 100 
mg TDS and Levetiracetam 750 mg BD. CSF HSV PCR 
came out to be negative, so Acyclovir was stopped.  
Autoimmune work up including ANA, AMA, and ASMA 
came out negative. 
On suspicion of non herpetic (autoimmune) encephalitis, 
she was given IVIg for 5 days and serum anti NMDA 
receptor antibodies were sent, which came out. 
Ultrasound pelvis showed no teratoma. She was 
discharged and advised proper nursing care and 
rehabilitation. Parents on telephonic follow up reported 
that her symptoms had resolved gradually and she had 
resumed usual activities.
DISCUSSION
Anti-NMDA receptor encephalitis is a neuroimmune 
syndrome with autoantibodies recognizing extracellular 
epitopes in NR1/NR2 heteromers of NMDA receptor (3), 
and attenuating NMDA receptor function through its 
internalization (4). Reduction in NMDA receptor activity 
results in inactivation of GABAergic neurons, causing 
disinhibition of excitatory pathways leading to  fronto- 
striatal syndrome which may manifest as psychosis, 
catatonia, mutism, rigidity and dystonia or affecting the 
brainstem that may cause  semi-rhythmic limb, trunk 
and bulbar movements. Autonomic instability, with 
hyperthermia, hypoventilation, blood pressure 
fluctuations, tachycardia, bradycardia, constipation or 
ileus may also occur due to involvement of 
dopaminergic, noradrenergic and cholinergic systems (5, 7). 
Anti-NMDA receptor encephalitis is more common in 
females (80%) with 23 years as median age of 
presentation and association with underlying ovarian 
teratoma in approximately half of the cases. Patients 
present with schizophrenia like psychiatric symptoms, 
usually preceded by fever, headache, or viral 
infection-like illness. After reaching the peak of 
psychosis, most patients develop memory problems, 
seizures, unresponsive/ catatonic state, decreased 
consciousness, orofacial-limb dyskinesias, autonomic 
instability and hypoventilation, with 88% of patients 
requiring intensive care support usually (5, 8, 9). This 
disorder is usually severe and can be fatal, but it is 
potentially reversible. Once patients recover from the 
hyperkinetic phase, gradual improvement is expected 
within months with  full recovery over 3 or more years. 
Recognition of symptom complex is the key to 
diagnosis. Brain MRI is  unremarkable in 50% of the 
cases. If abnormal, it usually shows increased signals in 
FLAIR and T2 sequences in cerebral, cerebellar or 
medial temporal lobes (9). CSF reveals nonspecific 
As our patient had no previous history of MS, it was 
difficult to differentiate it from other varieties of 
malignant demyelinating diseases especially ADEM. 
However, historical data, CSF analysis and radiographic 
characteristics of lesions suggested fulminant MS 
(table 2) (20). Radiological images were almost diagnostic 
of tumefactive demyelinating process based on size 
(2cm or more), location (periventricular and juxtacortical) 
and nature of lesions (confluent areas, mixed T2 
weighted iso and hyperintensity of enhanced regions, 
absence of cortical involvement and absence of a mass 
effect) (14,15,21,22) The lesions can be multifocal (83%) 
(as in our case) or unifocal (17%)(13) CSF analysis in our 
patient revealed absence of pleocytosis with elevated 
protein and presence of oligoclonal bands which is 
present in 11% to 33% of tumefactive MS cases,(13) 
favouring our diagnosis of tumefactive MS over ADEM. (23) 
Biopsy of the lesions is not routinely recommended to 
make a histological diagnosis. Standard treatment 
approach for fulminant MS variants is similar to severe 
relapses of MS. However, due to the rarity and high 
mortality associated with Marburg variant of MS, only a 
limited number of case reports  have shown some 
promising results for Plasma exchange and Mitoxantrone 
as treatment for acute phase and prevention of further 
relapses (4,5,24) There is one published study of 
Fulminant MS from Pakistan also from our centre where 
patients were treated with IV immunoglobulins followed 
by Mitoxantrone, with good outcomes(22).
Fig 4.  Follow up of patient in neurology clinic 3 months 
later.
We used Plasma exchange (PLEX) in this patient due to 
financial constraints. Mitoxantrone is an immun- 
omodulatory agent used as a disease modifying drug 
(DMD) to improve neurological disability and delay 
progression in relapsing remitting MS and secondary 
progressive MS (21). Several randomized clinical trials 
used 12mg/m2 dose administered once every 3 
months (21). We have previously used mitoxantrone for 
management of relapsing remitting MS (23) and as a 
DMD for Fulminant MS.22 Though FMS is a disease of 
severe morbidity and high mortality but better outcome 
can be expected if treated promptly and aggressively 
with disease modifying therapies early in the course of 
the disease.
CONCLUSION
Due to limitation of resources in our country, PLEX 
followed by Mitoxantrone may be a valuable option for 
treatment of fulminant multiple sclerosis.
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changes (11). EEG often reveals diffuse delta slowing 
without paroxysmal discharges (1, 2). Detection of NMDA 
receptor antibody in CSF or serum is helpful in making 
the diagnosis (3). Treatment is focused on tumor
resection and immunotherapy (corticosteroids, plasma 
exchange, intravenous immunoglobulin). In non- 
responders, second-line immunotherapy (rituximab or
cyclophosphamide or combined) is required. Recovery 
may also occur spontaneously. More than 75% of the 
patients recover completely or have mild sequelae,
while remaining  end up with  disability or death (12, 13).
CONCLUSION
Anti-NMDA receptor encephalitis has a recognizable 
pattern of presentation that may mimic psychiatric and 
infective diseases and if diagnosed correctly can be
effectively treated.
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came to be negative for malignancy. ANA was not done.
Patient showed gradual improvement in his clinical 
status and was discharged home 12 days later. He was 
given IV Mitoxantrone (12mg/m2), first dose given on 12 
day post admission and then once every 3 months. 
On discharge, EDSS improved from 9 to 5. He was 
followed in neurology clinic 3 months later with repeat 
MR imaging which showed interval regression in the size 
of previously noted lesions with no new activity (Fig.3). 
He showed remarkable clinical improvement, walking 
without support (EDSS 2) (Fig.4). He had no further 
relapse at 3 months.
DISCUSSION
Multiple sclerosis is the most common, idiopathic, 
inflammatory demyelinating disease of central nervous
system with a relapsing and remitting course (1)
Approximately 7% of patients may present with a 
fulminant disease (10). Tumefactive multiple sclerosis 
refers to large demyelinating lesions, typically 2 cm or 
larger in size, with surrounding mass effect, perilesional 
edema and open ring enhancement on gadolinium 
contrast (11,12,13). 
Figure 1. Axial diffusion weighted images(DWI) of Brain
(A) and (C) showing multiple nodular lesions of diffusion
restriction in bilateral parietal periventricular and 
subcortical regions, corresponding ADC images (B) 
and pons (D), largest one measuring 2.7×1.4 cm2.
They are iso-intense/hypointense on T1 (E) with subtle 
peripheral contrast enhancement (F) and correspondingly 
bright on FLAIR image with surrounding halo (G) and no 
significant mass effect.
First described nearly a century ago, Marburg variant of 
MS is a rare, acute, monophasic and highly aggressive 
form of MS, leading to severe morbidity or mortality 
within a few weeks to months.1 Due to its atypical 
clinical and radiographic features, it poses significant 
diagnostic dilemma (14). It presents with a polysymptomatic, 
monophasic illness (15) suggesting diffuse and extensive 
CNS involvement. 
Figure 2. Follow up MR images obtained 10 days later 
with new onset right hemiparesis and acute confusional 
state. DWI (A and C), ADC (B and D)and axial FLAIR 
images(E) showing development of new lesions and 
interval increase in size of previously observed multiple  
lesions which have become more confluent bilaterally.
Unlike classical MS, lesions occur simultaneously in all 
affected areas with large zones of confluent 
demyelination,(1,16) including cerebral hemisp- heres 
and brainstem (17) High mortality is associated with this 
variant especially with involvement of brainstem 
structures, (12,18,19) necessitating intensive care for 
aggressive management (15).First presentation of an 
acute, fulminant demyelinating event is the most 
common presentation in the course of tumefactive 
MS,13 hence early and prompt recognition of disease 
process and exclusion of infective, neoplastic, vasculitic and 
granulomatous disorder is of paramount importance.
Figure 3. Follow up MR images of same patient 
obtained at 3 months after resolution of acute neurological 
dysfunction. Axial T1 pre (A), post contrast (B) and FLAIR 
(C) images showing regression in size of previously noted 
lesions with no abnormal post contrast enhancement.
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